Zhangyi Luo

Targeting Xkr8 via nanoparticle-mediated in situ co-delivery of siRNA and chemotherapy drugs for cancer immunochemotherapy

Yuang Chen, Yixian Huang, Qinzhe Li et al. · Nature Nanotechnology · 2022 · 111 citations · Full text

Cancer Immunochemotherapy, Nanomedicine, Drug Targeting +6

Overcoming pancreatic cancer immune resistance by codelivery of CCR2 antagonist using a STING-activating gemcitabine-based nanocarrier

Zhuoya Wan, Haozhe Huang, Raymond E. West et al. · Materials Today · 2022 · 54 citations · Full text

Nanomedicine, Pancreatic Cancer, Medicine +7

Sensitizing Triple Negative Breast Cancer to Tamoxifen Chemotherapy via a Redox-Responsive Vorinostat-containing Polymeric Prodrug Nanocarrier

Weina Ma, Jingjing Sun, Jieni Xu et al. · Theranostics · 2020 · 47 citations · Full text

Creatine based polymer for codelivery of bioengineered MicroRNA and chemodrugs against breast cancer lung metastasis

Jieni Xu, Jingjing Sun, Pui Yan Ho et al. · Biomaterials · 2019 · 45 citations · Full text

Nanomedicine, Engineering, Polymer-drug Conjugate +10

Co-delivery of 2-Deoxyglucose and a glutamine metabolism inhibitor V9302 via a prodrug micellar formulation for synergistic targeting of metabolism in cancer

Zhangyi Luo, Jieni Xu, Jingjing Sun et al. · Acta Biomaterialia · 2020 · 45 citations · Full text

Drug Targeting, Medicine, Synergistic Targeting +7